Alarcon T, Ojeda-Thies C, Saez-Lopez P, et al. - This research was undertaken to investigate the profile of prescription of antiosteoporotic treatment at discharge after a hip fracture in the Spanish National Hip Fracture Registry. Researched recruited a sum of 6,701 individuals from 54 hospitals. This study examined the demographic variables, cognitive and functional status, pre-fracture osteoporosis treatment, fracture type, anesthetic risk, hospital volume, and antiosteoporotic prescription at discharge were analyzed. After a hip fracture, there is wide variability between hospitals about antiosteoporotic prescriptions. This is more likely to be started in individuals with better clinical, functional, and mental status and in those discharged from hospitals with larger volumes of individuals. These data suggest insights regarding the selection of individuals receiving secondary prevention and raises questions on who and how many should be treated.